Differential effect of covalent protein modification and glutathione depletion on the transcriptional response of Nrf2 and NF-κB

Autor: Alvin J. L. Chia, Paul Morgan, B. Kevin Park, Neil R. Kitteringham, Christopher E. Goldring, Shi Quan Wong
Rok vydání: 2010
Předmět:
Transcription
Genetic

medicine.disease_cause
environment and public health
Biochemistry
NF-κB
Mice
chemistry.chemical_compound
0302 clinical medicine
GSH
glutathione

ARE
anti-oxidant response element

0303 health sciences
NF-kappa B
respiratory system
Glutathione
3. Good health
Cell biology
DILI
drug-induced liver injury

RNAi
RNA interference

Liver
NAPQI
N-acetyl-p-benzoquinineimine

030220 oncology & carcinogenesis
NF-κB
NF-kappa B

CRMs
chemically reactive metabolites

Signal transduction
medicine.drug
Keap1
NAPQI
NF-E2-Related Factor 2
Cellular stress
DNCB
dinitrochlorobenzene

Biology
digestive system
Article
Nrf2
Cell Line
03 medical and health sciences
Transcriptional response
medicine
Animals
BSO
buthionine (S
R)-sulfoximine

030304 developmental biology
Pharmacology
Proteins
Nrf2
nuclear factor-erythroid 2 (NF-E2)-related factor

NFKB1
KEAP1
chemistry
RNAi
Drug metabolism
Oxidative stress
Protein Modification
Translational
Zdroj: Biochemical Pharmacology
ISSN: 0006-2952
DOI: 10.1016/j.bcp.2010.04.004
Popis: Graphical abstract CRMs activate Nrf2, but inhibit NF-κB, and GSH depletion without covalent modification activates both Nrf2 and NF-κB. This leads to cellular protection against the potentially harmful effects of redox perturbation.
Liver injury associated with exposure to therapeutic agents that undergo hepatic metabolism can involve the formation of reactive metabolites. These may cause redox perturbation which can result in oxidative stress as well as protein modification leading to activation or inhibition of cellular transcriptional responses. Nevertheless, the effects of these challenges on more than one transcriptional pathway simultaneously remain unclear. We have investigated two transcription factors known to be sensitive to electrophilic stress and redox perturbation, Nrf2 and NF-κB, in mouse liver cells. Cellular stress was induced by the probes: N-acetyl-p-benzoquinineimine (NAPQI), the reactive metabolite of acetaminophen; dinitrochlorobenzene (DNCB), a model electrophile; and buthionine (S,R)-sulfoximine (BSO), an inhibitor of glutamate-cysteine ligase. NAPQI, DNCB and BSO can all cause glutathione (GSH) depletion; however only NAPQI and DNCB can covalently bind proteins. We also employed RNAi to manipulate Keap1 (the inhibitor of Nrf2), Nrf2 itself and NF-κB-p65, to understand their roles in the response to drug stress. All three chemicals induced Nrf2, but NF-κB binding activity was only increased after BSO treatment. In fact, NF-κB binding activity decreased after exposure to NAPQI and DNCB. While RNAi depletion of Keap1 led to reduced toxicity following exposure to DNCB, depletion of Nrf2 and NF-κB augmented toxicity. Interestingly, increased Nrf2 caused by Keap1 depletion was reversed by co-depletion of NF-κB. We demonstrate that Keap1/Nrf2 and NF-κB respond differently to electrophiles that bind proteins covalently and the redox perturbation associated with glutathione depletion, and that crosstalk may enable NF-κB to partly influence Nrf2 expression during cellular stress.
Databáze: OpenAIRE